Pharmaceutical News

RSS

Opioid funding bill should address greater access to balanced pain management

The Alliance for Balanced Pain Management (AfBPM) made the following statement on the Obama administration’s plan to curb the opioid addiction crisis, which was released this morning as Congress prepares to tackle funding for related programs.

8 Jul 2016

New data shows Sandoz biosimilar etanercept candidate has equivalent efficacy to originator product

Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, today announced results from the EGALITY trial in which the primary endpoint of achieving equivalence in Psoriasis Area and Severity Index (PASI) 75 response rates at week 12 was met.

8 Jul 2016

Curza receives SBIR grant to develop new class of broad spectrum antibiotics

Curza Global, LLC, a company based on technology developed at the University of Utah, has been awarded a Phase I Small Business Innovation Research grant of $598,770 entitled "Natural product-inspired antibacterials with unique ribosomal binding" that will provide two years of support.

7 Jul 2016

New research shows how cholesterol medicine has beneficial effect on immune defence system

The cholesterol medicine simvastatin, which is one of the most commonly used pharmaceuticals in the world, also has a beneficial effect on the immune defence system with regard to diseases such as type 1 diabetes, multiple sclerosis and rheumatoid arthritis.

7 Jul 2016

NPS MedicineWise urges child care centres to increase awareness around misuse of antibiotics in young children

NPS MedicineWise has written to child care centres across Australia to enlist their support in responding to the growing problem of antibiotic resistance. Child care staff are well placed to help with education and increase awareness around the misuse of antibiotics in young children.

7 Jul 2016

Daclizumab drug offers new treatment option for people living with relapsing forms of MS in the UK

A new, first-in-class treatment which is believed to use a double-action approach to fight MS by rebalancing the immune system, has today been authorised in the UK for people living with relapsing forms (the most common type) of the disease.

7 Jul 2016

Scientists discover key cellular mechanism behind side-effects of antipsychotics

Since their development in the 1950s, antipsychotic drugs have been widely used to treat psychoses and neuropsychiatric disorders like schizophrenia. A debilitating side-effect of these drugs called parkinsonism limits their efficacy.

7 Jul 2016

Minoryx Therapeutics initiates phase 1 clinical trial of MIN-102

Minoryx Therapeutics, a drug development company specialized in the discovery and development of new drugs for orphan diseases, today announces the initiation of its first-in-man Phase 1 clinical trial for its lead compound MIN-102.

7 Jul 2016

Liraglutide drug lowers blood sugar levels in diabetic patients taking large doses of insulin

When Amy Sweat was 19 years old, while she was in the hospital recovering from surgery, she was diagnosed with Type 2 diabetes. Ms. Sweat was treated for her diabetes, first on oral drugs, then on increasingly larger doses of insulin, but the years went by and she never was able to achieve good blood sugar control.

6 Jul 2016

Regular marijuana use impacts the brain's natural response to rewards

Most people would get a little 'rush' out of the idea that they're about to win some money.

6 Jul 2016

Added benefit of idelalisib drug not proven for patients with CLL

Already in 2014, the German Institute for Quality and Efficiency in Health Care examined in an early benefit assessment whether idelalisib offers advantages over the appropriate comparator therapy for patients with chronic lymphocytic leukaemia (CLL).

6 Jul 2016

Zinc acetate lozenges may be effective in treating common cold

Zinc acetate lozenges may reduce the duration of the common cold by nearly 3 days, according to a recent analysis.

6 Jul 2016

New study identifies vitamin D deficiency among many Malaysian children with epilepsy

Long-term use of antiepileptic drugs is a significant risk factor for vitamin D deficiency in children with epilepsy.

6 Jul 2016

Diabetes drug metformin could help reduce toxic acid levels linked to MSUD

Maple Syrup Urine Disease (MSUD) is a rare inherited metabolic disorder involving the dysfunction of an enzyme which breaks down three essential amino acids: leucine, isoleucine and valine.

6 Jul 2016

PREVAIL IV trial opens in Liberia for EVD survivors with persistent traces of Ebola virus RNA

The Partnership for Research on Ebola Virus in Liberia, a U.S.-Liberia joint Clinical Research Partnership, today announced the opening of PREVAIL IV, a treatment trial for men who have survived Ebola virus disease (EVD) but continue to have evidence of Ebola virus genetic material, RNA, in their semen.

6 Jul 2016

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Amgen has announced that the European Commission (EC) has approved a variation to the marketing authorization for Kyprolis® (carfilzomib) to include use in combination with dexamethasone alone for adult patients with multiple myeloma who have received at least one prior therapy. The extended indication marks the second approval for Kyprolis by the EC in less than a year.

6 Jul 2016

Self-monitoring or self-management of anticoagulation therapy can help reduce thromboembolic events

Patients on long-term anticoagulation therapy who test their own blood-clotting time from home and continue to be managed by their GP are significantly less likely to experience a thromboembolic event, according to Oxford University researchers.

6 Jul 2016

Alnylam reports new results from investigational RNAi therapeutic programs

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today preliminary results from its ongoing Phase 2 open-label extension (OLE) studies with patisiran and revusiran, both investigational RNAi therapeutics targeting transthyretin (TTR) for the treatment of hereditary TTR-mediated amyloidosis (hATTR amyloidosis).

6 Jul 2016

Roche Diagnostics responds to HPV announcement

Roche Diagnostics welcomes the announcement by Public Health Minister, Jane Ellison, to introduce Human Papillomavirus (HPV) primary screening in England.

6 Jul 2016

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Mallinckrodt plc, a leading global specialty biopharmaceutical company, today announced new retrospective health economic data on H.P. Acthar® Gel (repository corticotropin injection; RCI), which may be an option for the management of multiple sclerosis (MS) relapses.

6 Jul 2016

Pharmaceutical News

Opioid funding bill should address greater access to balanced pain management

New data shows Sandoz biosimilar etanercept candidate has equivalent efficacy to originator product

Curza receives SBIR grant to develop new class of broad spectrum antibiotics

New research shows how cholesterol medicine has beneficial effect on immune defence system

NPS MedicineWise urges child care centres to increase awareness around misuse of antibiotics in young children

Daclizumab drug offers new treatment option for people living with relapsing forms of MS in the UK

Scientists discover key cellular mechanism behind side-effects of antipsychotics

Minoryx Therapeutics initiates phase 1 clinical trial of MIN-102

Liraglutide drug lowers blood sugar levels in diabetic patients taking large doses of insulin

Regular marijuana use impacts the brain's natural response to rewards

Added benefit of idelalisib drug not proven for patients with CLL

Zinc acetate lozenges may be effective in treating common cold

New study identifies vitamin D deficiency among many Malaysian children with epilepsy

Diabetes drug metformin could help reduce toxic acid levels linked to MSUD

PREVAIL IV trial opens in Liberia for EVD survivors with persistent traces of Ebola virus RNA

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Self-monitoring or self-management of anticoagulation therapy can help reduce thromboembolic events

Alnylam reports new results from investigational RNAi therapeutic programs

Roche Diagnostics responds to HPV announcement

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News